Page last updated: 2024-11-07

methylprednisolone acetate and Heart Failure

methylprednisolone acetate has been researched along with Heart Failure in 1 studies

Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.

Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Dutch, WA1
Norsworthy, GD1
Mayfield, MR1
Mayfield, JR1
Schmitt, CW1

Other Studies

1 other study available for methylprednisolone acetate and Heart Failure

ArticleYear
Incidences of steroid-induced diabetes mellitus and congestive heart failure in cats given non-immunosuppressive doses of methylprednisolone acetate: 1042 cats.
    The Canadian veterinary journal = La revue veterinaire canadienne, 2023, Volume: 64, Issue:11

    Topics: Adrenal Cortex Hormones; Animals; Cat Diseases; Cats; Diabetes Mellitus; Heart Failure; Incidence; M

2023